OLUKOTUN ADEOYE Y

CIK 00012426158 companiesDURHAM, NC

SEC Profile

Transactions

Companies

Filings

CIK

0001242615

Recent Transactions

50 trades

Award
ARROWHEAD PHARMACEUTICALS, INC.$ARWR
Common Stock
2025-12-16+7,819→ 43,600 total
Award
Tonix Pharmaceuticals Holding Corp.$TNXP
Stock Option
2025-05-13+10,000→ 10,000 total
Sale
ARROWHEAD PHARMACEUTICALS, INC.$ARWR
Common Stock
2025-01-23$21.00/sh−959→ 35,781 total
Sale
ARROWHEAD PHARMACEUTICALS, INC.$ARWR
Common Stock
2024-12-27$20.00/sh−2,850→ 36,740 total
Award
ARROWHEAD PHARMACEUTICALS, INC.$ARWR
Common Stock
2024-12-18$22.99/sh+16,733→ 39,590 total
Other
Tonix Pharmaceuticals Holding Corp.$TNXP
Common Stock, par value $0.001
2024-06-10$1.91/sh−0.812→ 0 total
Award
Tonix Pharmaceuticals Holding Corp.$TNXP
Stock Option
2024-05-23+104,621→ 104,621 total
Award
ARROWHEAD PHARMACEUTICALS, INC.$ARWR
Common Stock
2023-12-15$25.41/sh+14,987→ 22,854 total
Award
Tonix Pharmaceuticals Holding Corp.$TNXP
Stock Option
2023-05-08+60,000→ 60,000 total
Sale
ARROWHEAD PHARMACEUTICALS, INC.$ARWR
Common Stock
2023-03-03$32.65/sh−11,350→ 7,867 total
Award
ARROWHEAD PHARMACEUTICALS, INC.$ARWR
Common Stock
2023-01-10+7,867→ 19,217 total
Award
ARROWHEAD PHARMACEUTICALS, INC.$ARWR
Common Stock
2023-01-10+4,593→ 4,593 total
Award
Tonix Pharmaceuticals Holding Corp.$TNXP
Stock Option
2022-05-09+2,131,500→ 2,131,500 total
Award
ARROWHEAD PHARMACEUTICALS, INC.$ARWR
Common Stock
2022-01-07+6,400→ 11,350 total
Sale
ARROWHEAD PHARMACEUTICALS, INC.$ARWR
Common Stock
2022-01-03$64.26/sh−1,890→ 7,110 total
Sale
ARROWHEAD PHARMACEUTICALS, INC.$ARWR
Common Stock
2022-01-03$65.04/sh−1,916→ 5,194 total
Sale
ARROWHEAD PHARMACEUTICALS, INC.$ARWR
Common Stock
2022-01-03$66.25/sh−244→ 4,950 total
Sale
ARROWHEAD PHARMACEUTICALS, INC.$ARWR
Common Stock
2021-09-13$63.76/sh−2,250→ 11,750 total
Sale
ARROWHEAD PHARMACEUTICALS, INC.$ARWR
Common Stock
2021-09-13$63.76/sh−2,750→ 9,000 total
Award
Tonix Pharmaceuticals Holding Corp.$TNXP
Stock Option
2021-05-10+270,882→ 270,882 total
Award
ARROWHEAD PHARMACEUTICALS, INC.$ARWR
Common Stock
2021-01-01+9,000→ 14,000 total
Purchase
Tonix Pharmaceuticals Holding Corp.$TNXP
Common Stock, par value $0.001
2020-08-13$0.94/sh+5,350→ 5,350 total
Award
Tonix Pharmaceuticals Holding Corp.$TNXP
Stock Option
2020-05-04+75,000→ 75,000 total
Award
Tonix Pharmaceuticals Holding Corp.$TNXP
Stock Option
2019-05-06+30,000→ 30,000 total
Award
Tonix Pharmaceuticals Holding Corp.$TNXP
Stock Option
2018-09-05+15,000→ 15,000 total
Award
Diadexus, Inc.
Common Stock
2013-08-06+5,958→ 5,958 total
Award
Diadexus, Inc.
Stock Option (Right to Buy)
2013-07-31+55,000→ 55,000 total
Disposition from Tender
BIOCLINICA INC
Common Stock
2013-03-12$7.25/sh−52,000→ 0 total
Award
BIOCLINICA INC
Restricted Stock Units
2012-05-16+12,000→ 52,000 total
Disposition to Issuer
ICAGEN INC
Common Stock
2011-10-27$6.00/sh−7,062→ 0 total
Disposition from Tender
ICAGEN INC
Common Stock
2011-09-02$6.00/sh−11,141→ 7,062 total
Exercise/Conversion
ICAGEN INC
Common Stock
2011-09-02$4.08/sh+1,250→ 16,203 total
Exercise/Conversion
ICAGEN INC
Common Stock
2011-09-02$2.56/sh+2,000→ 18,203 total
Exercise/Conversion
ICAGEN INC
Common Stock
2011-09-02$3.36/sh+1,250→ 14,953 total
Exercise/Conversion
ICAGEN INC
Director Stock Option (right to buy)
2011-09-02+2,000→ 0 total
Exercise/Conversion
ICAGEN INC
Director Stock Option (right to buy)
2011-09-02+1,250→ 0 total
Exercise/Conversion
ICAGEN INC
Director Stock Option (right to buy)
2011-09-02+1,250→ 0 total
Award
ICAGEN INC
Director Stock Option (right to buy)
2011-06-03+2,000→ 2,000 total
Award
BIOCLINICA INC
Restricted Stock Units
2011-05-11+10,000→ 40,000 total
Award
ICAGEN INC
Common Stock
2011-01-03+7,062→ 13,703 total
Award
ICAGEN INC
Director Stock Option (right to buy)
2010-06-04+10,000→ 10,000 total
Award
BIOCLINICA INC
Restricted Stock Units
2010-05-12+10,000→ 30,000 total
Award
ICAGEN INC
Common Stock
2010-01-04+26,539→ 53,134 total
Award
BIOCLINICA INC
Restricted Stock Units
2009-07-08+10,000→ 20,000 total
Award
ICAGEN INC
Director Stock Option (right to buy)
2009-06-03+10,000→ 10,000 total
Award
ICAGEN INC
Common Stock
2009-03-05+26,595→ 26,595 total
Award
BIOCLINICA INC
Restricted Stock Units
2008-08-25+10,000→ 10,000 total
Award
VIA Pharmaceuticals, Inc.
Stock Option (right to buy)
2007-12-17+120,000→ 120,000 total
Award
VIA Pharmaceuticals, Inc.
Stock Option (right to buy)
2007-06-05+55,758→ 55,758 total
Award
VIA Pharmaceuticals, Inc.
Common Stock
2007-06-05+59,624→ 59,624 total

Companies

Recent Filings

Address

C/O ICAGEN, INC. 4222 EMPEROR BOULEVARD, SUITE 350

DURHAM, NC, 27703

View on SEC.gov